Journal Issue Page - European Urology

Viewing articles 11-20 of 41

Previous 10 articles 1 2 3 4 5 Next 10 articles

topReviews

Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence?

Christian Seitz, Evangelos Liatsikos, Francesco Porpiglia, Hans-Göran Tiselius and Ulrike Zwergel

19 June 2009 | pages 455 - 471

Abstract Full Text Full-Text PDF (1,0 MB)

Create Platinum Slide Series

topSurgery in Motion

Periurethral Suspension Stitch During Robot-Assisted Laparoscopic Radical Prostatectomy: Description of the Technique and Continence Outcomes

Vipul R. Patel, Rafael F. Coelho, Kenneth J. Palmer and Bernardo Rocco

16 June 2009 | pages 472 - 478

Abstract Full Text Full-Text PDF (449 KB) Activate Visual

Online Extra

Create Platinum Slide Series

topProstate Cancer

$Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy$ Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy

Dominique Helley, Eugeniu Banu, Abdelkader Bouziane, Adela Banu, Florian Scotte, Anne-Marie Fischer and Stéphane Oudard

20 June 2008 | pages 479 - 485

Abstract Full Text Full-Text PDF (500 KB)

Create Platinum Slide Series

Editorial Comment on: Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy

Antonio Lopez-BeltranRodolfo Montironi

pages 484 - 485

Full Text Full-Text PDF (3,6 MB)

Mutations in the AXIN1 Gene in Advanced Prostate Cancer

George W. Yardy, David C. Bicknell, Jennifer L. Wilding, Sylvia Bartlett, Ying Liu, Bruce Winney, Gareth D.H. Turner, Simon F. Brewster and Walter F. Bodmer

23 May 2008 | pages 486 - 494

Abstract Full Text Full-Text PDF (701 KB)

Create Platinum Slide Series

Editorial Comment on: Mutations in the AXIN1 Gene in Advanced Prostate Cancer

Jack A. Schalken

page 494

Full Text Full-Text PDF (89 KB)

topBladder Cancer

Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study

Andreas Böhle, Herbert Leyh, Christian Frei, Michael Kühn, Reinhold Tschada, Tobias Pottek, Walter Wagner, Helmut H. Knispel, Wolfgang von Pokrzywnitzki, Ferruh Zorlu, Karin Helsberg, Birgit Lübben, Victoria Soldatenkova, Clemens Stoffregen and Hartwig Büttner on behalf of the S274 Study Group.

19 June 2009 | pages 495 - 503

Abstract Full Text Full-Text PDF (535 KB)

EU*ACME

Create Platinum Slide Series

topUrothelial Cancer

Topical Chemotherapy in Human Urothelial Carcinoma Explants: A Novel Translational Tool for Preclinical Evaluation of Experimental Intravesical Therapies

Christian Bolenz, Eva-Maria Ikinger, Philipp Ströbel, Lutz Trojan, Annette Steidler, Mario I. Fernández, Patrick Honeck, Ute Gabriel, Christel Weiss, Rainer Grobholz, Peter Alken and Maurice Stephan Michel

30 July 2008 | pages 504 - 511

Abstract Full Text Full-Text PDF (853 KB)

Create Platinum Slide Series

The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?

Marco Roscigno, Shahrokh F. Shariat, Vitaly Margulis, Pierre Karakiewicz, Mesut Remzi, Eiji Kikuchi, Richard Zigeuner, Alon Weizer, Arthur Sagalowsky, Karim Bensalah, Jay D. Raman, Christian Bolenz, Wassim Kassou, Theresa M. Koppie, Christopher G. Wood, Jeffrey Wheat, Cord Langner, Casey K. Ng, Umberto Capitanio, Roberto Bertini, Mario I. Fernández, Shuji Mikami, Masaru Isida, Philipp Ströbel and Francesco Montorsi

18 June 2009 | pages 512 - 519

Abstract Full Text Full-Text PDF (336 KB)

EU*ACME

Create Platinum Slide Series

Editorial Comment on: The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?

Guido Dalbagni

18 June 2009 | page 519

Full Text Full-Text PDF (65 KB)

Viewing articles 11-20 of 41

Previous 10 articles 1 2 3 4 5 Next 10 articles

European Urology

archive

European Urology

topReviews

Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence?

topSurgery in Motion

Periurethral Suspension Stitch During Robot-Assisted Laparoscopic Radical Prostatectomy: Description of the Technique and Continence Outcomes

topProstate Cancer

Editorial Comment on: Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy

Mutations in the AXIN1 Gene in Advanced Prostate Cancer

Editorial Comment on: Mutations in the AXIN1 Gene in Advanced Prostate Cancer

topBladder Cancer

Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study

topUrothelial Cancer

Topical Chemotherapy in Human Urothelial Carcinoma Explants: A Novel Translational Tool for Preclinical Evaluation of Experimental Intravesical Therapies

The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?

Editorial Comment on: The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?

Search

Listing options

Free Content

Resource Centres

Top 10 cited